According to the results of a retrospective cohort study, in diabetic patients hospitalized in the general ward, hypoglycemia is common and is associated with an increased length of stay (LOS) and higher mortality rate.

As the economy slumped, waistlines surged, according to the latest national obesity report card, which found that adult obesity rates increased in 23 states over the past year. At the same time, not a single state posted a decrease in obesity, and three of every ten children living in 30 states …

Men aged 35-54 are almost twice as likely to have diabetes compared to their female counterparts, reveals a new report “Diabetes in the UK 2009.”

US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include …

According to the results of a new study, both obesity and Type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in premenopausal women.

Sodium bicarbonate supplementation significantly slowed loss of kidney function and improved nutrition status in patients with advanced chronic kidney disease, data from a two-year study showed.

An eye condition picked up in annual eye exams can aid early identification of a variety of other health conditions. Ninety-eight percent of study participants who had a grayish-white ring around the cornea — a condition called corneal arcus — also had metabolic problems related to conditions such as diabetes, high …

A genome-wide study uncovered five genetic variants that may contribute to blood pressure specifically in African-Americans.

Diabetes patients taking NovoLog((R)) (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the FDA approval of a labeling change. Novo Nordisk announced last week that this makes NovoLog((R)) the first and only rapid-acting insulin with this extended in-use time.

Anyone who defends the pharmaceutical industry has to be ready to hear, over and over and over, about how much it spends on sales and marketing versus R&D. This is thought to be a telling point about where the priorities really are. I’ve addressed this one several times, and my …